Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preventing infectious disease with passive immunization.

L Zeitlin1, R A Cone, T R Moench

  • 1ReProtect, LLC, 703 Stags Head Road, Baltimore, MD 21286, USA. Lzeitlin@epicyte.com

Microbes and Infection
|July 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition.

Mucosal immunology·2017
Same author

Prevention and treatment of Clostridium perfringens epsilon toxin intoxication in mice with a neutralizing monoclonal antibody (c4D7) produced in Nicotiana benthamiana.

Toxicon : official journal of the International Society on Toxinology·2014
Same author

Developing multipurpose reproductive health technologies: an integrated strategy.

AIDS research and treatment·2013
Same author

Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice.

Journal of cellular biochemistry·2003
Same author

Diffusion of macromolecules and virus-like particles in human cervical mucus.

Biophysical journal·2001
Same author

Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices.

AIDS (London, England)·2001
Same journal

The extent of monocytic myeloid suppressor cells induction determines the host immune response during Mycobacterium avium infection.

Microbes and infection·2025
Same journal

Culture-attenuated pathogenic Leptospira lose the ability to survive complement lytic activity due to decreased C4BP uptake.

Microbes and infection·2025
Same journal

Exploring the link between genetically predicted plasma cathepsins and COVID-19: A mendelian randomization study of susceptibility and severity.

Microbes and infection·2025
Same journal

Laboratory parameters and serum tube agglutination test as markers for brucellosis treatment response.

Microbes and infection·2025
Same journal

Corrigendum to "Lactococcus lactis and Bifidobacterium longum attenuate Clostridioides difficile- or Clostridium symbiosum-induced colitis and depression/anxiety-like behavior in male mice" [Microb Infect 27(7) (2025) 105560].

Microbes and infection·2025
Same journal

Disrupted Microbiome-Metabolome networks underlie gut barrier and immune imbalance in severe fever with thrombocytopenia syndrome.

Microbes and infection·2025
See all related articles

Passive immunization with antibodies offers protection against infectious diseases. Monoclonal antibodies show promise for developing new passive immunization strategies against various infections.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Therapeutics

Background:

  • Antibodies are crucial for immune defense, providing passive immunity.
  • Passive immunization leverages antibodies to prevent or treat infections.
  • Monoclonal antibodies represent a significant advancement in antibody-based therapies.

Purpose of the Study:

  • To review clinical trials of passive immunization.
  • To explore the potential of monoclonal antibodies for infectious disease prevention.
  • To discuss novel strategies for passive immunization.

Main Methods:

  • Review of successful clinical trials in passive immunization.
  • Analysis of the characteristics of monoclonal antibodies.
  • Consideration of applications in infectious disease control.

Related Experiment Videos

Main Results:

  • Clinical trials demonstrate the efficacy of passive immunization.
  • Monoclonal antibodies possess unique qualities suitable for therapeutic development.
  • Passive immunization strategies are being advanced.

Conclusions:

  • Passive immunization is an effective method for preventing infectious diseases.
  • Monoclonal antibodies offer unique advantages for developing new passive immunization approaches.
  • Further development of monoclonal antibody-based passive immunization is warranted for broad infectious disease protection.